Navigation Links
FDA Approves Valcyte(R) (valganciclovir hydrochloride) to Prevent Cytomegalovirus (CMV) Disease in Pediatric Patients Who Receive Heart or Kidney Transplants
Date:8/30/2009

NUTLEY, N.J., Aug. 31 /PRNewswire-FirstCall/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Valcyte(R) (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV) disease in pediatric kidney and heart transplant patients (4 months to 16 years of age) at high risk of developing CMV disease. The FDA also approved a new pediatric oral solution formulation for Valcyte, which will allow easier administration to pediatric patients 4 months to 16 years of age.

"Children receiving organ transplants are especially vulnerable to infection because of their reduced immunity, and the invasive procedure of a transplant can put them at higher risk of contracting CMV infection," noted Richard Freeman, M.D., Vice Chair for Research, Department of Surgery, Professor of Surgery, Tufts Medical Center. "Prevention and medication dosing can be challenging because children are not small adults. The new oral formulation and information about how to administer the medicine will help doctors treat their pediatric transplant patients."

CMV (herpesvirus) infects approximately 80 percent of the U.S. population depending on age. In the majority of cases the virus lies dormant in the body throughout life, but can be reactivated at times when the immune system is weakened (such as transplant patients and AIDS patients). In patients who have received an organ transplant, CMV infection usually develops during the first few months after transplantation, and may cause complications in the lungs, kidneys, nervous system, liver, and gastrointestinal tract. CMV can lead to the loss of the transplanted organ, and studies have shown that the virus has been correlated with an increased risk of death in post-transplant patients.

Over the past 21 years, more than 35,000 children ages 17 and younger have been transp
'/>"/>

SOURCE Roche
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria
2. Health Canada Approves Abbotts XIENCE V(R) Drug Eluting Stent
3. First 5 California Approves $81.4 Million Contribution to Help Restore Healthy Families Programs Viability
4. Video: FDA Approves EMBEDA(TM) For Management of Moderate to Severe Chronic Pain
5. FDA Approves New 3000 IU Vial Size for Kogenate(R) FS, antihemophilic factor (recombinant)
6. FDA Approves LIVALO(R) for Primary Hypercholesterolemia and Combined Dyslipidemia
7. FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
8. House Committee Approves Amendment Eliminating Cost-Sharing for Medicaid Preventive Services
9. FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension
10. FDA Approves Sculptra(R)Aesthetic, a Facial Injectable for Correction of Nasolabial Folds and Other Facial Wrinkles
11. Kaiser Permanente Approves $11 Million in Community Benefit Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... the particle might someday ease accompanying lung infections , , ... severe pneumonia when infected with the swine flu virus, ... why. , A key to the severity of the ... (TH17), which helps the immune system fight off germs ... in swine-flu patients at 10 Spanish hospitals last summer ...
(Date:12/17/2009)... to announce its newly redesigned Web site: www.psanj.com . PSANJ ... Area often featured in publications such as New York magazine and ... ... December 17, 2009 -- Plastic Surgery Arts of New Jersey (PSANJ) ... . PSANJ is a leading cosmetic surgery center in the New ...
(Date:12/17/2009)... ,for the R&D Informatics Industry, , ... ... Institute is pleased to announce the participation of seven world ... Systems conference to be held on February 3-5, 2010 at ... meeting has been integrated in the Informatics Channel at CHI,s ...
(Date:12/17/2009)... hired Deirdre Byrne to lead the firm’s Interim Leadership division as ... experience in healthcare consulting, Byrne will assume her duties at B. ... ... 17, 2009 -- B. E. Smith recently hired Deirdre ... president. A seasoned executive with nearly 20 years of experience in ...
(Date:12/17/2009)... customary for the holidays to wreak havoc on healthy ... workouts often get short-changed and nutrition is left to ... Waters, it is not impossible to enjoy the holidays ... Raisins and Waters have teamed up to offer advice ... season and get a jump start on New Year,s ...
Breaking Medicine News(10 mins):Health News:Plastic Surgery Arts of New Jersey (PSANJ) Launches New Web Site 2Health News:Plastic Surgery Arts of New Jersey (PSANJ) Launches New Web Site 3Health News:Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference 2Health News:Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference 3Health News:Deirdre Byrne Joins B. E. Smith as Senior Vice President, Interim Leadership Services 2Health News:Deirdre Byrne Joins B. E. Smith as Senior Vice President, Interim Leadership Services 3Health News:Celebrity Fitness Trainer Valerie Waters and California Raisins Offer Advice on How to Jump Start the New You in the New Year 2Health News:Celebrity Fitness Trainer Valerie Waters and California Raisins Offer Advice on How to Jump Start the New You in the New Year 3
... objectives in 30 states, particularly in the areas of ... The state of the economy did not deter ... million in grants at its fourth-quarter board meeting in ... in grants for 2008 as a whole, the most ...
... Medical Center has been verified as a Level I Trauma Center-Pediatric by ... , ... Washington, DC (Vocus) February 11, 2009 -- Children,s National Medical ... the Committee on Trauma of the American College of Surgeons (ACS). Children,s ...
... to Be Held at 9:00 A.M. - EXTON, Pa., ... fourth quarter and year end financial results for 2008 are ... the open of the U.S. financial markets.The company will host ... Eastern Time on the same day. During the conference ...
... recent study conducted by researchers at Wake Forest University ... abilities drop as average blood sugar levels rise in ... in this month,s issue of Diabetes Care . ... sub-study of the Action to Control Cardiovascular Risk in ...
... 11 Mesa Laboratories, Inc. (Nasdaq: ... Directors has declared a regular quarterly cash dividend ... payable on March 16, 2009 to shareholders of ... 27, 2009.Mesa Laboratories develops, acquires, manufactures and markets ...
... Emageon Inc. (Nasdaq:, EMAG ), a leader ... health care networks, announced today that it has ... Board: HSSO) that it does not,expect that Stanford ... to consummate the parties, merger transaction today. ...
Other Medicine News:Health News:Kresge Foundation Meets Economic Downturn Head on, Awarding a Record $63.6 Million in Grants in Fourth Quarter 2008 2Health News:Kresge Foundation Meets Economic Downturn Head on, Awarding a Record $63.6 Million in Grants in Fourth Quarter 2008 3Health News:Kresge Foundation Meets Economic Downturn Head on, Awarding a Record $63.6 Million in Grants in Fourth Quarter 2008 4Health News:Kresge Foundation Meets Economic Downturn Head on, Awarding a Record $63.6 Million in Grants in Fourth Quarter 2008 5Health News:Kresge Foundation Meets Economic Downturn Head on, Awarding a Record $63.6 Million in Grants in Fourth Quarter 2008 6Health News:Kresge Foundation Meets Economic Downturn Head on, Awarding a Record $63.6 Million in Grants in Fourth Quarter 2008 7Health News:Kresge Foundation Meets Economic Downturn Head on, Awarding a Record $63.6 Million in Grants in Fourth Quarter 2008 8Health News:Kresge Foundation Meets Economic Downturn Head on, Awarding a Record $63.6 Million in Grants in Fourth Quarter 2008 9Health News:Kresge Foundation Meets Economic Downturn Head on, Awarding a Record $63.6 Million in Grants in Fourth Quarter 2008 10Health News:Children's National Medical Center Trauma Center Receives Highest Verification from American College of Surgeons 2Health News:ViroPharma to Release 2008 Fourth Quarter and Full Year Financial Results on February 24, 2009 2Health News:Higher blood sugar levels linked to lower brain function in diabetics, study shows 2Health News:Emageon Provides Update Regarding Merger Transaction 2Health News:Emageon Provides Update Regarding Merger Transaction 3
(Date:12/17/2009)... Decision Resources, one of the world,s ... healthcare issues, finds that the cost of Roche/Chugai,s ... side-effect profile, are cited most frequently by surveyed ... Avastin for non-small-cell lung cancer treatment in Germany, ... The new Special European Physician & Payer Forum ...
(Date:12/17/2009)... MedX Limited, the manufacturer and global distributor of ... subsidiary of WellTek Incorporated (OTC Bulletin Board: WTKN), ... exercise and medical machines to ... India, Scotland, South Korea, Spain and Switzerland. ... be used in various medical rehabilitation and fitness ...
(Date:12/17/2009)... Inc., (OTC Bulletin Board: SCIE) disclosed today that its ... letter to shareholders: ,, As the end of the ... the recent closing of a $4.3 million round of ... ramping our business performance as we head into 2010. ... force. We are increasing our sales and marketing activities ...
Breaking Medicine Technology:Surveyed European Oncologists Cite Cost Most Frequently as the Factor Preventing Their Use of Avastin for Non-Small-Cell Lung Cancer 2Surveyed European Oncologists Cite Cost Most Frequently as the Factor Preventing Their Use of Avastin for Non-Small-Cell Lung Cancer 3WellTek Subsidiary MedX Limited Increases Presence in Global Market 2WellTek Subsidiary MedX Limited Increases Presence in Global Market 3WellTek Subsidiary MedX Limited Increases Presence in Global Market 4SpectraScience Releases Shareholder Newsletter 2SpectraScience Releases Shareholder Newsletter 3SpectraScience Releases Shareholder Newsletter 4SpectraScience Releases Shareholder Newsletter 5Chinese Scientists Develop Database on the Liver 61322 1Elsevier pilots new research tool Reflect in its premier life science journal Cell 10722 1Elsevier pilots new research tool Reflect in its premier life science journal Cell 10722 2Many Kids Feel Threatened in the Classroom 61317 1Many Kids Feel Threatened in the Classroom 61317 2
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Infusion Cannula, 6.0mm....
Infusion Cannula, 4.0mm....
Medicine Products: